New Discovery of Biomarker to Improve Diagnosis, Prognosis and Treatment of Esophageal Squamous Cell Carcinoma
Monday, January 6, 2014 - 10:00
in Health & Medicine
Esophageal Squamous Cell Carcinoma (ESCC), the major histological form of esophageal cancer, is the leading cause of cancer death worldwide. Scientists from the National University of Singapore (NUS) have discovered a biomarker, called adenosine deaminase acting on RNA-1 (ADAR1), which has the potential to improve the diagnosis, prognosis and treatment of this disease.